U S Department of Health and Human Services Improving the health, safety and well-being of America
  CMS Home > Medicare > Medicare Coverage - General Information > Medicare Coverage Database > Indexes Home > NCD Chapters > View NCD

Medicare Coverage Database

NCD for Oxygen Treatment of Inner Ear/Carbon Therapy (50.5)

Publication Number

100-3

Manual Section Number

50.5

Version Number

1

Effective Date of this Version

8/1/1978

Benefit Category

Physicians' Services

Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.

Indications and Limitations of Coverage

Oxygen (95 percent) and carbon dioxide (5 percent) inhalation therapy for inner ear disease, such as endolymphatic hydrops and fluctuant hearing loss, is not reasonable and necessary. The therapeutic benefit deriving from this procedure is highly questionable.



basket Add to basket  |  envelope icon - email Email this to a friend  |  new search New Search



Page Last Modified: 4/23/2009 7:26:58 AM

Help with File Formats and Plug-Ins

Submit Feedback





www2